Emergent BioSolutions (EBS) Amortization - Intangibles: 2018-2025
Historic Amortization - Intangibles for Emergent BioSolutions (EBS) over the last 8 years, with Sep 2025 value amounting to $16.3 million.
- Emergent BioSolutions' Amortization - Intangibles changed negligibly% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year increase of 0.15%. This contributed to the annual value of $65.1 million for FY2024, which is 0.76% down from last year.
- As of Q3 2025, Emergent BioSolutions' Amortization - Intangibles stood at $16.3 million, which was up 0.62% from $16.2 million recorded in Q2 2025.
- Over the past 5 years, Emergent BioSolutions' Amortization - Intangibles peaked at $17.9 million during Q4 2022, and registered a low of $14.0 million during Q4 2021.
- For the 3-year period, Emergent BioSolutions' Amortization - Intangibles averaged around $16.3 million, with its median value being $16.3 million (2025).
- In the last 5 years, Emergent BioSolutions' Amortization - Intangibles rose by 27.86% in 2022 and then fell by 9.50% in 2023.
- Emergent BioSolutions' Amortization - Intangibles (Quarterly) stood at $14.0 million in 2021, then increased by 27.86% to $17.9 million in 2022, then decreased by 9.50% to $16.2 million in 2023, then increased by 0.62% to $16.3 million in 2024, then remained steady at $16.3 million in 2025.
- Its Amortization - Intangibles was $16.3 million in Q3 2025, compared to $16.2 million in Q2 2025 and $16.3 million in Q1 2025.